Biography of Carmen Valcarce
Last update: April 8, 2024Career
Carmen was Project Leader, Glucokinase activator project for Novo Nordisk. Carmen Valcarce joined MacAndrews & Forbes in 2007. Carmen served as Senoir Vice President, Preclinical development and Senior Vice President, Scientific Liaison for MacAndrews & Forbes.
Carmen Valcarce is currently Executive Vice President and Chief Scientific Officer at vTv Therapeutics - View - vTv Therapeutics org chart
Create your alert
to follow the career of Carmen Valcarce.
Education
In 1989, Carmen Valcarce completed a PhD in Biochemistry and Molecular Biology at Universidad Autónoma de Madrid.
They have also studied at Universidad Autónoma de Madrid :
Find more alumni from Universidad Autónoma de Madrid
More about Carmen Valcarce
Selected links
Do you need to know more about Carmen Valcarce? More results.
Participate
Social media
- Carmen Valcarce on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Carmen Valcarce
The colleagues of Carmen Valcarce
Company Colleagues
- At vTv Therapeutics, Carmen Valcarce has 17 colleagues including Paul Sekhri (CEO & President), Fahed Al Marzooqi (Director)…
Industry Colleagues
- In the Pharmaceuticals industry, Carmen Valcarce has 19,337 colleagues in 1,860 companies located in 69 countries. 8,433 executive movements have been recorded in the last 12 months. Learn more about Pharmaceuticals.
Report an error
Update the org chart details of Carmen Valcarce.
